These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 36212242)

  • 1. Acute Liver Failure Secondary to Remdesivir in the Treatment of COVID-19.
    Lin K; Gausman V; Poles M; Popov V
    ACG Case Rep J; 2022 Oct; 9(10):e00866. PubMed ID: 36212242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic Disorders With the Use of Remdesivir for Coronavirus 2019.
    Montastruc F; Thuriot S; Durrieu G
    Clin Gastroenterol Hepatol; 2020 Nov; 18(12):2835-2836. PubMed ID: 32721580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Remdesivir-Associated Sinus Arrest in COVID-19: A Potential Indication for Close Cardiac Monitoring.
    Gregory GE; Gregory HM; Liaqat H; Ghaly MM; Johnson-Pich KD
    Cureus; 2022 Feb; 14(2):e22328. PubMed ID: 35317046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Remdesivir-Associated Acute Liver Failure in a COVID-19 Patient: A Case Report and Literature Review.
    Ahmed-Khan MA; Matar G; Coombes K; Moin K; Joseph BM; Funk CM
    Cureus; 2023 Jan; 15(1):e34221. PubMed ID: 36852363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic manifestations of COVID-19 and effect of remdesivir on liver function in patients with COVID-19 illness.
    Aleem A; Mahadevaiah G; Shariff N; Kothadia JP
    Proc (Bayl Univ Med Cent); 2021 Mar; 34(4):473-477. PubMed ID: 34219928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The journey of remdesivir: from Ebola to COVID-19.
    Pardo J; Shukla AM; Chamarthi G; Gupte A
    Drugs Context; 2020; 9():. PubMed ID: 32547625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delayed Initiation of Remdesivir in a COVID-19-Positive Patient.
    Hillaker E; Belfer JJ; Bondici A; Murad H; Dumkow LE
    Pharmacotherapy; 2020 Jun; 40(6):592-598. PubMed ID: 32281114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Remdesivir-Induced Liver Injury in a Patient With Coronavirus Disease 2019 and History of Congestive Hepatopathy.
    Dividis GP; Papadopoulos GE; Karageorgiou I; Kotronis G
    Cureus; 2022 Dec; 14(12):e32353. PubMed ID: 36514704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Remdesivir administration for Japanese COVID-19 patients undergoing maintenance hemodialysis: a retrospective observation with six case reports.
    Ito J; Kimura M; Toya T; Isozumi K; Kawaji A; Isozaki Y; Fukagawa M
    Ren Replace Ther; 2022; 8(1):14. PubMed ID: 35433033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Remdesivir-Induced Marked Sinus Bradycardia in COVID-19.
    Ahmed T; Lodhi SH; Ahmed T
    Cureus; 2022 Jul; 14(7):e27249. PubMed ID: 36035063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Remdesivir Treatment for COVID 19 in Pregnant Patients with Moderate to Severe Symptoms: Serial Case Report.
    Saroyo YB; Rumondang A; Febriana IS; Harzif AK; Irwinda R
    Infect Dis Rep; 2021 May; 13(2):437-443. PubMed ID: 34067822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extended Remdesivir Infusion for Persistent Coronavirus Disease 2019 Infection.
    Martinez MA; Chen TY; Choi H; Hwang M; Navarathna D; Hao L; Gale M; Camus G; Ramirez HE; Jinadatha C
    Open Forum Infect Dis; 2022 Aug; 9(8):ofac382. PubMed ID: 36039098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ADME and Pharmacokinetic Properties of Remdesivir: Its Drug Interaction Potential.
    Deb S; Reeves AA; Hopefl R; Bejusca R
    Pharmaceuticals (Basel); 2021 Jul; 14(7):. PubMed ID: 34358081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bradycardia Related to Remdesivir During COVID-19: Persistent or Permanent?
    Maheshwari M; Athiraman H
    Cureus; 2021 Nov; 13(11):e19919. PubMed ID: 34956798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative Safety and Efficacy of Remdesivir Versus Remdesivir Plus Convalescent Plasma Therapy (CPT) and the Effect of Timing of Initiation of Remdesivir in COVID-19 Patients: An Observational Study From North East India.
    Sharma DJ; Deb A; Sarma P; Mallick B; Bhattacharjee P
    Cureus; 2021 Nov; 13(11):e19976. PubMed ID: 34984135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Remdesivir in Treatment of COVID-19: A Systematic Benefit-Risk Assessment.
    Davies M; Osborne V; Lane S; Roy D; Dhanda S; Evans A; Shakir S
    Drug Saf; 2020 Jul; 43(7):645-656. PubMed ID: 32468196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liposomal remdesivir inhalation solution for targeted lung delivery as a novel therapeutic approach for COVID-19.
    Li J; Zhang K; Wu D; Ren L; Chu X; Qin C; Han X; Hang T; Xu Y; Yang L; Yin L
    Asian J Pharm Sci; 2021 Nov; 16(6):772-783. PubMed ID: 34703490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complete heart block associated with Remdesivir in COVID-19: a case report.
    Selvaraj V; Bavishi C; Patel S; Dapaah-Afriyie K
    Eur Heart J Case Rep; 2021 Jul; 5(7):ytab200. PubMed ID: 34222786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sinus Bradycardia Associated with Remdesivir Treatment in COVID-19: A Case Report and Literature Review.
    Barkas F; Styla CP; Bechlioulis A; Milionis H; Liberopoulos E
    J Cardiovasc Dev Dis; 2021 Feb; 8(2):. PubMed ID: 33673216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The nucleoside antiviral prodrug remdesivir in treating COVID-19 and beyond with interspecies significance.
    Yan D; Ra OH; Yan B
    Anim Dis; 2021; 1(1):15. PubMed ID: 34778881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.